SuperSonic Imagine to Present Newly Upgraded Aixplorer(R) Ultrasound Platform at JFR in Paris

AIX-EN-PROVENCE, FRANCE--(Marketwired - Oct 13, 2016) - SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, today announced that it will present the new version of Aixplorer for the first time at Journées Françaises de Radiologie (JFR) in Paris, October 14th to 17th. The newly released upgrade to Aixplorer, the UltraFast™ ultrasound system, enhances performance, workflow and efficiency while adding exceptional new features.

"We are pleased to present for the first time Aixplorer's new capabilities to practitioners, especially during breast cancer awareness month. Key features we will be demonstrating include the new TriVu* real-time simultaneous mode with B-mode, ShearWave™ Elastography (SWE™) and color flow imaging, an exclusive feature that offers simultaneous real-time visualization of anatomy, flow and tissue stiffness," said Jacques Souquet, Founder and Chief Innovation Officer of SuperSonic Imagine. "Attendees focused on therapeutic follow-up management of cancer treatment, a topic at JFR 2016, will be interested in Aixplorer's new comprehensive breast package, a combination of new probes designed especially for breast imaging and three essential innovations to aid visualization: SWE to improve ultrasound specificity, 3D Ultrasound for a color-coded map of tissue stiffness, and TriVu for breast anatomy, flow and tissue stiffness in a single screen."

Dr. Claudia Kurtz of Lucerne Cantonal Hospital - Breast Diagnostics in Switzerland said, "Aixplorer's latest version shows advancement in several respects. First, the new 18 MHz probe provides substantially better B-mode image quality allowing to better describe the breast lesion`s margin. Also, it is now possible to simultaneously view tissue stiffness with Shearwave with Color Doppler in real time, quite an improvement in workflow. The Color mode on its own has also been enhanced, thus being able to visualize even smaller vessels. Overall, with these impressive advancements, breast lesions can now be more quickly and easily assessed without the need of time-consuming conventional ultrasound techniques."